12-114385476-C-T
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM2PM5PP3_StrongPP5_Moderate
The NM_181486.4(TBX5):c.755G>A(p.Ser252Asn) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S252I) has been classified as Likely pathogenic.
Frequency
Consequence
NM_181486.4 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- Holt-Oram syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
 - heart conduction diseaseInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
 
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| TBX5 | NM_181486.4  | c.755G>A | p.Ser252Asn | missense_variant, splice_region_variant | Exon 7 of 9 | ENST00000405440.7 | NP_852259.1 | |
| TBX5 | NM_000192.3  | c.755G>A | p.Ser252Asn | missense_variant, splice_region_variant | Exon 7 of 9 | NP_000183.2 | ||
| TBX5 | NM_080717.4  | c.605G>A | p.Ser202Asn | missense_variant, splice_region_variant | Exon 6 of 8 | NP_542448.1 | ||
| TBX5 | XM_017019912.2  | c.803G>A | p.Ser268Asn | missense_variant, splice_region_variant | Exon 7 of 9 | XP_016875401.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| TBX5 | ENST00000405440.7  | c.755G>A | p.Ser252Asn | missense_variant, splice_region_variant | Exon 7 of 9 | 1 | NM_181486.4 | ENSP00000384152.3 | ||
| TBX5 | ENST00000310346.8  | c.755G>A | p.Ser252Asn | missense_variant, splice_region_variant | Exon 7 of 9 | 1 | ENSP00000309913.4 | |||
| TBX5 | ENST00000349716.9  | c.605G>A | p.Ser202Asn | missense_variant, splice_region_variant | Exon 6 of 8 | 1 | ENSP00000337723.5 | |||
| TBX5 | ENST00000526441.1  | c.755G>A | p.Ser252Asn | missense_variant, splice_region_variant | Exon 6 of 7 | 1 | ENSP00000433292.1 | 
Frequencies
GnomAD3 genomes  Cov.: 32 
GnomAD4 exome Cov.: 31 
GnomAD4 genome  Cov.: 32 
ClinVar
Submissions by phenotype
TBX5-related disorder    Pathogenic:1 
The TBX5 c.755G>A variant is predicted to result in the amino acid substitution p.Ser252Asn. To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. This variant has been confirmed de novo in an individual with TBX5-related disorder (Internal Data, PreventionGenetics). A different substitution affecting the same amino acid (p.Ser252Ile) has been in association with Holt-Oram syndrome (Fan et al. 2003. PubMed ID: 12499378; Fan et al. 2009. PubMed ID: 19648116). Taken together, the c.755G>A (p.Ser252Asn) variant is interpreted as likely pathogenic. -
not provided    Pathogenic:1 
Alters the last nucleotide of the exon and is predicted to destroy the splice donor site and result in aberrant splicing, although in the absence of functional evidence the actual effect of this sequence change is unknown; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at